Erik Morrow

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension

Regulation of Mitochondrial Morphology by Positive Feedback Interaction Between PKCδ and Drp1 in Vascular Smooth Muscle Cell

AMPK: guardian of metabolism and mitochondrial homeostasis

A global view of pulmonary hypertension

Ageing as a risk factor for neurodegenerative disease

Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming

Dynamin-related protein inhibitor downregulates reactive oxygen species levels to indirectly suppress high glucose-induced hyperproliferation of vascular smooth muscle cells

Reactive oxygen species (ROS) as pleiotropic physiological signalling agents

The Metabolic Basis of Pulmonary Arterial Hypertension

Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells

Mitophagy and Alzheimer’s Disease: Cellular and Molecular Mechanisms

Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension

Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology

Relevant Issues in the Pathology and Pathobiology of Pulmonary Hypertension

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

<p>Reactive Oxygen Species: Drivers of Physiological and Pathological Processes</p>

Ferroptosis: mechanisms, biology and role in disease

Down syndrome

The Crossroads of Iron with Hypoxia and Cellular Metabolism. Implications in the Pathobiology of Pulmonary Hypertension

A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease

How Mitochondrial Dynamism Orchestrates Mitophagy

Metabolic control of cell death

Corylin Inhibits Vascular Cell Inflammation, Proliferation and Migration and Reduces Atherosclerosis in ApoE-Deficient Mice

Fundamental Mechanisms of Immune Checkpoint Blockade Therapy

Mitochondrial Fission Inhibitors Suppress Endothelin-1-Induced Artery Constriction

Antioxidant, Antimicrobial and Antiviral Properties of Herbal Materials

Reactive Oxygen Species in Metabolic and Inflammatory Signaling

Dynamin-related protein 1 mediates low glucose-induced endothelial dysfunction in human arterioles

Dynamin-Related Protein 1–Mediated Mitochondrial Mitotic Fission Permits Hyperproliferation of Vascular Smooth Muscle Cells and Offers a Novel Therapeutic Target in Pulmonary Hypertension

FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate

Lung ¹⁸ F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension

PGC1α-mediated Mitofusin-2 Deficiency in Female Rats and Humans with Pulmonary Arterial Hypertension

Dynamin‐related protein 1 (Drp1)‐mediated diastolic dysfunction in myocardial ischemia‐reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission

Role of Dynamin-Related Protein 1 (Drp1)-Mediated Mitochondrial Fission in Oxygen Sensing and Constriction of the Ductus Arteriosus